Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapy.
Vansteenkiste J, Lara PN Jr, Le Chevalier T, Breton JL, Bonomi P, Sandler AB, Socinski MA, Delbaldo C, McHenry B, Lebwohl D, Peck R, Edelman MJ. Vansteenkiste J, et al. Among authors: delbaldo c. J Clin Oncol. 2007 Aug 10;25(23):3448-55. doi: 10.1200/JCO.2006.09.7097. Epub 2007 Jul 2. J Clin Oncol. 2007. PMID: 17606973 Clinical Trial.
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease.
Delbaldo C, Michiels S, Rolland E, Syz N, Soria JC, Le Chevalier T, Pignon JP. Delbaldo C, et al. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD004569. doi: 10.1002/14651858.CD004569.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2012 Apr 18;(4):CD004569. doi: 10.1002/14651858.CD004569.pub3 PMID: 17943820 Updated. Review.
[New drugs in bronchial cancer].
Delbaldo C, Faivre S, Monnerat C, Le Chevalier T. Delbaldo C, et al. Presse Med. 2002 May 11;31(17):802-9. Presse Med. 2002. PMID: 12148365 Review. French.
Combined modality treatment of lung cancer (NSCLC and SCLC).
Delbaldo C, Le Péchoux C, Le Chevalier T. Delbaldo C, et al. Cancer Chemother Biol Response Modif. 2002;20:677-95. Cancer Chemother Biol Response Modif. 2002. PMID: 12703230 Review. No abstract available.
Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.
Blay JY, Le Cesne A, Ray-Coquard I, Bui B, Duffaud F, Delbaldo C, Adenis A, Viens P, Rios M, Bompas E, Cupissol D, Guillemet C, Kerbrat P, Fayette J, Chabaud S, Berthaud P, Perol D. Blay JY, et al. Among authors: delbaldo c. J Clin Oncol. 2007 Mar 20;25(9):1107-13. doi: 10.1200/JCO.2006.09.0183. J Clin Oncol. 2007. PMID: 17369574 Clinical Trial.
56 results